» Articles » PMID: 38199633

Assessing the Impact of Diverse Mask Types on COPD Patients: a Randomised Controlled Trial Study Protocol

Overview
Journal BMJ Open
Specialty General Medicine
Date 2024 Jan 10
PMID 38199633
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Wearing masks has proven beneficial in preventing respiratory pathogen infections in individuals with chronic obstructive pulmonary disease (COPD). However, the impact of different mask types on physiological indicators and daily physical activity in COPD patients remains uncertain. This study aims to assess the immediate effects of various mask types on cardiopulmonary function indicators, subjective perceptions and the 6-minute walking distance (6MWD) in individuals with COPD.

Methods And Analysis: This randomised controlled trial will enrol 129 stable COPD patients. Participants will be randomly divided into three groups: control, N95 mask and surgical mask groups. Each group will undergo both a 6-minute seated test and a 6-minute walk test (6MWT), without or with their respective masks. A 10-minute interval will be provided between the two phases. The primary indicators of the study include the 6MWD and blood oxygen saturation. Secondary outcomes encompass blood pressure, pulse rate, Borg score, Rate of Perceived Exertion (RPE) score and subjective perception score. Oxygen saturation, pulse rate and blood pressure will be recorded four times during the trial, while Borg and RPE scores will be compared before and after the 6MWT. Additionally, subjective perception scores will be collected after each mask-wearing stage.

Ethics And Dissemination: This study has received approval from the Ethics Committee of the Affiliated Hospital of Gansu University of Chinese Medicine (approval number: 202335). We plan to disseminate research results through publication in a peer-reviewed journal or presentation at a conference.

Trial Registration Number: ChiCTR2300074554.

References
1.
Roberts M, Cho J, Sandoz J, Wheatley J . Oxygen desaturation and adverse events during 6-min walk testing in patients with COPD. Respirology. 2015; 20(3):419-25. DOI: 10.1111/resp.12471. View

2.
Fikenzer S, Uhe T, Lavall D, Rudolph U, Falz R, Busse M . Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity. Clin Res Cardiol. 2020; 109(12):1522-1530. PMC: 7338098. DOI: 10.1007/s00392-020-01704-y. View

3.
Sun C, He B, Mu D, Li P, Zhao H, Li Z . Public Awareness and Mask Usage during the COVID-19 Epidemic: A Survey by China CDC New Media. Biomed Environ Sci. 2020; 33(8):639-645. PMC: 7523132. DOI: 10.3967/bes2020.085. View

4.
Xu M, Wang J, Shan L, An X . The Current Landscape of COPD-Related Clinical Trials Registered on the World Health Organization's International Clinical Trials Registry Platform: A Comprehensive Analysis of Study Characteristics and Publication Status. Chronic Obstr Pulm Dis. 2023; 10(4):400-411. PMC: 10699491. DOI: 10.15326/jcopdf.2023.0417. View

5.
. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1):111-7. DOI: 10.1164/ajrccm.166.1.at1102. View